InvestorsHub Logo
Followers 0
Posts 568
Boards Moderated 0
Alias Born 05/24/2013

Re: None

Sunday, 06/09/2013 10:41:35 PM

Sunday, June 09, 2013 10:41:35 PM

Post# of 443
Sunshine Biopharma is committed to developing novel therapies for the treatment of various forms of aggressive cancer types. The Company's initial drug candidate, Adva-27a, is a small molecule that has proven effective against different types of multidrug resistant cancer cell lines including breast cancer (MCF-7/MDR), small-cell lung cancer (H69AR), uterine carcinoma (MES-SA/Dx5) and pancreatic cancer (Panc-1).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMGN News